AJANTPHARM

Ajanta Pharma Share Price Ajanta Pharma

₹2,113.1
-2.3 (-0.11%)
  • Advice
  • Hold
21 February, 2024 22:56 BSE: 532331 NSE: AJANTPHARMISIN: INE031B01049

Start SIP in Ajanta Pharma

Start SIP

Ajanta Pharma Performance

Day Range

  • Low 2,100
  • High 2,157
₹ 2,113

52 Week Range

  • Low 1,132
  • High 2,354
₹ 2,113
  • Open Price2,128
  • Previous Close2,115
  • Volume71112

Ajanta Pharma Share Price

  • Over 1 Month -4.13%
  • Over 3 Month 7.31%
  • Over 6 Month 18.09%
  • Over 1 Year 73.25%

Ajanta Pharma Key Statistics

P/E Ratio 36.2
PEG Ratio 1.9
Market Cap Cr 26,607
Price to Book Ratio 7.9
EPS 43.4
Dividend 2.4
Relative Strength Index 44.11
Money Flow Index 47.27
MACD Signal 8.52
Average True Range 68.97
Ajanta Pharma Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,0859451,015849
Operating Expenses Qtr Cr 758672738704
Operating Profit Qtr Cr 327274277145
Depreciation Qtr Cr 33333232
Interest Qtr Cr 2211
Tax Qtr Cr 85786331
Net Profit Qtr Cr 220212212117
IndicatorMar 2023
Total Revenue Annual Cr 3,544
Operating Expenses Annual Cr 2,712
Operating Profit Annual in Cr 699
Depreciation Cr 127
Interest Annual Cr 5
Tax Annual Cr 141
Net Profit Annual Cr 559
IndicatorMar 2023
Cash from Operating Activity Annual Cr 736
Cash from Investing Activity Annual Cr -501
Cash from Financing Annual Activity Cr -105
Net Cash Flow Annual Cr 130
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 3,246
Fixed Assets Annual Cr 1,693
Total Non Current Assets Annual Cr 1,754
Total Current Assets Annual Cr 2,551
Total Assets Annual Cr 4,305
IndicatorMar 2023
Book Value Per Share Annual Rs 257
ROE Annual % 17
ROCE Annual % 21
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 24
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,1051,0281,021882
Operating Expenses Qtr Cr 791738750732
Operating Profit Qtr Cr 314291271149
Depreciation Qtr Cr 34343333
Interest Qtr Cr 2211
Tax Qtr Cr 81816130
Net Profit Qtr Cr 210195208122
IndicatorMar 2023
Total Revenue Annual Cr 3,841
Operating Expenses Annual Cr 2,959
Operating Profit Annual in Cr 783
Depreciation Cr 131
Interest Annual Cr 6
Tax Annual Cr 157
Net Profit Annual Cr 588
IndicatorMar 2023
Cash from Operating Activity Annual Cr 792
Cash from Investing Activity Annual Cr -560
Cash from Financing Annual Activity Cr -108
Net Cash Flow Annual Cr 124
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 3,388
Fixed Assets Annual Cr 1,706
Total Non Current Assets Annual Cr 1,845
Total Current Assets Annual Cr 2,834
Total Assets Annual Cr 4,679
IndicatorMar 2023
Book Value Per Share Annual Rs 268
ROE Annual % 17
ROCE Annual % 21
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 24

Ajanta Pharma Technicals

EMA & SMA

Current Price
₹2,113.1
-2.3 (-0.11%)
pointer
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • ₹2,157.62
  • 50 Day
  • ₹2,112.66
  • 100 Day
  • ₹1,999.55
  • 200 Day
  • ₹1,817.39
  • 20 Day
  • ₹2,168.42
  • 50 Day
  • ₹2,122.42
  • 100 Day
  • ₹1,983.06
  • 200 Day
  • ₹1,759.61

Ajanta Pharma Resistance and Support

PIVOT
₹2,123.15
Resistance
First Resistance 2,146.65
Second Resistance 2,180.20
Third Resistance 2,203.70
RSI 44.11
MFI 47.27
MACD Single Line 8.52
MACD -4.67
Support
First Resistance 2,089.60
Second Resistance 2,066.10
Third Resistance 2,032.55

Ajanta Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 73,108 3,202,861 43.81
Week 102,881 7,049,392 68.52
1 Month 129,387 7,770,963 60.06
6 Month 177,566 9,741,273 54.86

Ajanta Pharma Result Highlights

Ajanta Pharma Synopsis

NSE-Medical-Generic Drugs

Ajanta Pharma Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3411.27 Cr. and Equity Capital is Rs. 25.27 Cr. for the Year ended 31/03/2023. Ajanta Pharma Ltd. is a Public Limited Listed company incorporated on 31/12/1979 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1979PLC022059 and registration number is 022059.
Market Cap 26,607
Sales 3,894
Shares in Float 4.28
No of funds 255
Yield 1.7
Book Value 8.22
U/D Vol ratio 1.1
LTDebt / Equity
Alpha 0.19
Beta 0.53

Ajanta Pharma

Owner NameDec-23Sep-23Jun-23Apr-23
Promoters 66.21%66.21%66.21%66.21%
Mutual Funds 13.86%12.84%13.07%13.72%
Insurance Companies 2.15%2.07%1.64%1.36%
Foreign Portfolio Investors 9.11%9.99%10.19%10.03%
Financial Institutions/ Banks
Individual Investors 7.07%7.21%6.92%6.95%
Others 1.6%1.68%1.97%1.73%

Ajanta Pharma Management

Name Designation
Mr. Mannalal B Agrawal Chairman
Mr. Madhusudan B Agrawal Vice Chairman
Mr. Yogesh M Agrawal Managing Director
Mr. Rajesh M Agrawal Joint Managing Director
Mr. Chandrakant M Khetan Independent Director
Mr. K H Viswanathan Independent Director
Mr. Prabhakar R Dalal Independent Director
Dr. Anjana Grewal Independent Director

Ajanta Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ajanta Pharma Corporate Action

Date Purpose Remarks
2024-01-31 Quarterly Results & 2nd Interim Dividend
2023-10-31 Quarterly Results
2023-07-27 Quarterly Results
2023-05-05 Audited Results
2023-03-10 Buy Back of shares
Date Purpose Remarks
2024-02-08 INTERIM Rs.26.00 per share(1300%)Second Interim Dividend
2023-08-04 SPECIAL Rs.15.00 per share(750%)Special Dividend
2023-08-04 INTERIM Rs.10.00 per share(500%)First Interim Dividend
2022-11-14 INTERIM Rs.7.00 per share(350%)Interim Dividend
2021-11-10 INTERIM Rs.9.50 per share(475%)Interim Dividend
Date Purpose Remarks
2022-06-23 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma FAQs

What is Share Price of Ajanta Pharma ?

Ajanta Pharma share price is ₹2,113 As on 21 February, 2024 | 22:42

What is the Market Cap of Ajanta Pharma ?

The Market Cap of Ajanta Pharma is ₹26607.2 Cr As on 21 February, 2024 | 22:42

What is the P/E ratio of Ajanta Pharma ?

The P/E ratio of Ajanta Pharma is 36.2 As on 21 February, 2024 | 22:42

What is the PB ratio of Ajanta Pharma ?

The PB ratio of Ajanta Pharma is 7.9 As on 21 February, 2024 | 22:42

What people are saying about us!

Raja Mohan Challa Raja Mohan Challa

Great app, you will have very good understanding of fundamental and technical analysis if you look into detail, Which will help you to invest and timing. Thanks

Ravi K Tiwari Ravi K Tiwari

New avtaar is quite progressive, better than before.

santosh kashyap santosh kashyap

Superb app which has daily recommendations also..

Uttam Kumar Sangam Uttam Kumar Sangam

good investing app

Sultan Shaikh Sultan Shaikh

excellent app and service

Q2FY23